amortization (3) 2,490 2,533 4,979 5,070
severance costs (4) 95 664 705 679
Total Adjustments $3,572 $4,859 $7,681 $9,335
Per share effect of
adjustments 0.07 0.10 0.16 0.20
Adjusted earnings per share $(0.07) $(0.03) $(0.19) $(0.14)
We use the term "adjusted earnings per share" or "adjusted EPS" to refer to GAAP earnings per share excluding share-based compensation, purchase accounting revenue and cost of sales fair value adjustments due to business combination accounting rules, amortization of intangible assets, and restructuring and severance costs. Adjusted earnings per share is calculated by subtracting the total per share effect of these adjustments from GAAP EPS.
The adjustments are as follows:
1) We exclude share-based compensation from this measure because share- based compensation plans involve sensitive measures and assumptions in calculating the expense that could vary dramatically between us and our peers, which we believe makes comparisons of long-range trends difficult for management or investors, and could result in overstating or understating the costs of developing, producing, supporting and selling our products and the costs to support our internal operating structure.
2) We exclude purchase accounting revenue fair value adjustments (net
of associated costs) from this measure due to business combination
accounting rules that would otherwise result in such revenues (and
associated costs) to be recognized on a continuing GAAP basis because
management expects the contractual arrangements underlying these revenues
will be renewed and that our investors will use this adjustment as a basis
for measuring our ongoing performance, although
|SOURCE Caliper Life Sciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved